marketcaparena

PRTA

PROTHENA CORP PUBLIC LTD CO

Company overview

Market capitalization
$447.66M
Employees
67
Latest publication
2026-09-29
About PROTHENA CORP PUBLIC LTD CO

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau antibody which is in Phase 2 clinical trial to treat Alzheimer's disease; PRX019, an investigational antibody which is in Phase 1 clinical trial for the treatment of neurodegenerative diseases; and PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer's disease. In addition, it develops discovery- and late-preclinical-stage programs include TDP-43 CYTOPE for the treatment of amyotrophic lateral sclerosis; PRX012, a next-generation anti-Aß antibody which is in phase 1 clinical trial to treat Alzheimer's disease; and PRX012-TfR, a preclinical program for the treatment of Alzheimer's disease. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. Prothena Corporation plc was incorporated in 2012 and is based in Dublin, Ireland.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue1,010,000USD51,084,000USD21,000USD4,420,000USD2,828,000USD2,123,000USD970,000USD132,014,000USD
Research Development8,798,000USD12,627,000USD14,586,000USD40,517,000USD50,811,000USD50,172,000USD50,723,000USD57,510,000USD
General And Administrative Expenses10,899,000USD———————
Total Operating Expenses22,111,000USD24,375,000USD26,290,000USD89,036,000USD68,409,000USD67,020,000USD67,483,000USD73,637,000USD
Operating Income-21,101,000USD25,791,000USD-27,211,000USD-84,616,000USD-65,581,000USD-64,897,000USD-66,513,000USD58,377,000USD
Total Other Income Expense Net2,520,000USD6,931,000USD5,632,000USD3,651,000USD4,208,000USD5,396,000USD6,677,000USD6,470,000USD
Net Interest Income2,553,000USD2,416,000USD2,646,000USD3,794,000USD4,348,000USD5,387,000USD6,743,000USD6,521,000USD
Income Before Tax-18,581,000USD32,722,000USD-21,579,000USD-80,965,000USD-61,373,000USD-59,501,000USD-59,836,000USD64,847,000USD
Income Tax Expense2,000USD1,000USD10,000USD44,802,000USD-1,178,000USD-1,545,000USD-835,000USD-2,039,000USD
Net Income-18,583,000USD32,721,000USD-21,589,000USD-125,767,000USD-60,195,000USD-57,956,000USD-59,001,000USD66,886,000USD
Cost Of Revenue—918,000USD942,000USD——913,000USD—57,510,000USD
Gross Profit—50,166,000USD-921,000USD4,420,000USD2,828,000USD2,123,000USD970,000USD132,014,000USD
Selling General Administrative—12,666,000USD12,646,000USD15,910,000USD17,598,000USD16,848,000USD16,760,000USD16,127,000USD
Interest Income—2,416,000USD2,646,000USD3,794,000USD4,348,000USD5,387,000USD6,743,000USD6,521,000USD
Tax Provision—1,000USD10,000USD44,802,000USD-1,178,000USD-1,545,000USD-835,000USD-2,039,000USD
Net Income From Continuing Ops—32,721,000USD-21,589,000USD-125,767,000USD-60,195,000USD-57,956,000USD-59,001,000USD66,886,000USD
Ebit—32,722,000USD-21,579,000USD-52,007,000USD-61,373,000USD-59,501,000USD-59,836,000USD64,847,000USD
Ebitda—33,640,000USD-20,637,000USD-51,782,000USD-61,150,000USD-59,280,000USD-59,610,000USD65,078,000USD
Depreciation And Amortization—918,000USD942,000USD225,000USD223,000USD221,000USD226,000USD231,000USD
Reconciled Depreciation—184,000USD218,000USD225,000USD223,000USD221,000USD226,000USD231,000USD
Unclassified Operating Expenses———32,609,000USD————
Selling And Marketing Expenses———————893,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
Total Revenue135,157,000USD91,370,000USD53,905,000USD200,577,000USD853,000USD955,000USD27,519,000USD1,055,000USD
Cost Of Revenue3,585,000USD220,571,000USD6,741,000USD82,284,000USD74,884,000USD101,183,000USD134,547,000USD119,534,000USD
Gross Profit135,157,000USD91,370,000USD53,905,000USD200,577,000USD853,000USD-100,228,000USD27,519,000USD1,055,000USD
Research Development222,519,000USD220,571,000USD135,562,000USD82,284,000USD74,884,000USD101,183,000USD134,547,000USD119,534,000USD
Selling General Administrative67,199,000USD61,835,000USD49,900,000USD46,318,000USD38,703,000USD42,482,000USD48,226,000USD41,056,000USD
Total Operating Expenses289,718,000USD282,406,000USD185,462,000USD128,602,000USD113,587,000USD143,665,000USD182,773,000USD160,590,000USD
Operating Income-154,561,000USD-191,036,000USD-131,557,000USD71,975,000USD-112,734,000USD-158,855,000USD-155,254,000USD-159,535,000USD
Interest Income25,816,000USD31,014,000USD6,349,000USD42,000USD1,369,000USD6,389,000USD3,546,000USD556,000USD
Net Interest Income25,816,000USD31,014,000USD6,349,000USD42,000USD1,369,000USD2,692,000USD-142,000USD556,000USD
Income Before Tax-128,930,000USD-160,480,000USD-125,605,000USD71,921,000USD-111,427,000USD-156,115,000USD-157,603,000USD-158,964,000USD
Income Tax Expense-6,620,000USD-13,452,000USD-8,656,000USD4,946,000USD-283,000USD-470,000USD-4,366,000USD1,144,000USD
Tax Provision-6,620,000USD-13,452,000USD-8,656,000USD4,946,000USD-283,000USD-470,000USD-4,366,000USD1,144,000USD
Net Income-122,310,000USD-147,028,000USD-116,949,000USD66,975,000USD-111,144,000USD-155,645,000USD-153,237,000USD-160,108,000USD
Net Income From Continuing Ops-122,310,000USD-147,028,000USD-116,949,000USD66,975,000USD-111,144,000USD-155,645,000USD-153,237,000USD-160,108,000USD
Ebit-128,930,000USD-160,480,000USD-131,557,000USD71,975,000USD-112,734,000USD-156,115,000USD-155,254,000USD-159,535,000USD
Ebitda-128,037,000USD-159,552,000USD-130,813,000USD78,778,000USD-105,757,000USD-152,899,000USD-152,187,000USD-157,108,000USD
Depreciation And Amortization893,000USD928,000USD744,000USD6,803,000USD6,977,000USD3,216,000USD3,067,000USD2,427,000USD
Reconciled Depreciation893,000USD928,000USD744,000USD6,803,000USD6,977,000USD3,216,000USD3,067,000USD—
Total Other Income Expense Net25,631,000USD30,556,000USD5,952,000USD-54,000USD1,307,000USD2,740,000USD-2,349,000USD571,000USD
Interest Expense——6,696,000USD6,749,000USD8,284,000USD3,697,000USD3,688,000USD863,000USD
Net Income Applicable To Common Shares——-116,949,000USD66,975,000USD-111,144,000USD-155,645,000USD-153,237,000USD-160,108,000USD
Non Operating Income Net Other———-96,000USD-62,000USD48,000USD-2,207,000USD15,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets302,579,000USD349,894,000USD326,804,000USD352,628,000USD399,066,000USD495,336,000USD547,108,000USD595,254,000USD
Cash And Equivalents288,193,000USD———————
Total Current Assets292,013,000USD339,201,000USD315,193,000USD339,974,000USD385,475,000USD436,173,000USD485,412,000USD534,984,000USD
Other Current Assets3,820,000USD9,739,000USD7,662,000USD9,131,000USD14,040,000USD18,238,000USD14,024,000USD15,722,000USD
Other Non Current Assets482,000USD———————
Total Liabilities15,688,000USD———————
Total Current Liabilities11,658,000USD32,517,000USD40,843,000USD51,436,000USD67,807,000USD48,459,000USD48,501,000USD46,422,000USD
Other Current Liabilities5,237,000USD———————
Total Stockholder Equity286,891,000USD312,616,000USD280,474,000USD294,989,000USD324,331,000USD437,680,000USD486,926,000USD534,362,000USD
Total Equity Including Noncontrolling Interest286,891,000USD———————
Deferred Revenue620,000USD———————
Property Plant Equipment Net9,224,000USD9,351,000USD10,269,000USD11,312,000USD12,253,000USD12,898,000USD13,789,000USD14,654,000USD
Accounts Payable1,941,000USD4,299,000USD5,875,000USD10,503,000USD12,198,000USD16,027,000USD7,770,000USD10,330,000USD
Short Term Debt2,961,000USD2,893,000USD2,886,000USD2,879,000USD2,853,000USD2,628,000USD2,610,000USD2,613,000USD
Common Stock517,000USD530,000USD538,000USD538,000USD538,000USD538,000USD538,000USD538,000USD
Retained Earnings-1,332,295,000USD-1,313,712,000USD-1,346,433,000USD-1,324,844,000USD-1,288,303,000USD-1,162,536,000USD-1,102,341,000USD-1,044,385,000USD
Total Liab—37,278,000USD46,330,000USD57,639,000USD74,735,000USD57,656,000USD60,182,000USD60,892,000USD
Other Current Liab—23,695,000USD29,418,000USD35,369,000USD47,656,000USD21,906,000USD29,271,000USD24,647,000USD
Capital Stock—530,000USD538,000USD538,000USD538,000USD538,000USD538,000USD538,000USD
Cash—329,462,000USD307,531,000USD330,843,000USD371,435,000USD417,935,000USD471,388,000USD519,262,000USD
Cash And Short Term Investments—329,462,000USD307,531,000USD330,843,000USD371,435,000USD417,935,000USD471,388,000USD519,262,000USD
Current Deferred Revenue—1,630,000USD2,664,000USD2,685,000USD5,100,000USD7,898,000USD8,850,000USD8,832,000USD
Net Debt—-321,808,000USD-293,671,000USD-321,761,000USD-361,654,000USD-407,732,000USD-460,545,000USD-507,768,000USD
Short Long Term Debt Total—7,654,000USD13,860,000USD9,082,000USD9,781,000USD10,203,000USD10,843,000USD11,494,000USD
Property Plant Equipment Gross—16,587,000USD17,321,000USD18,224,000USD19,655,000USD21,297,000USD22,097,000USD22,741,000USD
Common Stock Shares Outstanding—54,109,000shares53,831,000shares53,830,000shares53,827,000shares53,827,000shares53,815,000shares53,790,000shares
Non Current Assets Total—10,693,000USD11,611,000USD12,654,000USD13,591,000USD59,163,000USD61,696,000USD60,270,000USD
Non Current Liabilities Total—4,761,000USD5,487,000USD6,203,000USD6,928,000USD9,197,000USD11,681,000USD14,470,000USD
Non Currrent Assets Other—482,000USD482,000USD482,000USD478,000USD1,354,000USD4,668,000USD4,614,000USD
Net Working Capital—306,684,000USD274,350,000USD288,538,000USD317,668,000USD387,714,000USD436,911,000USD488,562,000USD
Unclassified Non Current Liabilities—4,761,000USD5,487,000USD6,203,000USD6,928,000USD9,197,000USD11,681,000USD14,470,000USD
Unclassified Equity—1,625,268,000USD1,625,831,000USD1,618,757,000USD1,611,558,000USD1,599,140,000USD1,588,191,000USD1,577,671,000USD
Unclassified Non Current Assets—————44,911,000USD43,239,000USD41,002,000USD
Net Receivables——————0USD0USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets326,804,000USD547,108,000USD696,382,000USD758,035,000USD609,366,000USD332,975,000USD419,268,000USD498,796,000USD
Other Current Assets7,662,000USD14,024,000USD15,293,000USD8,630,000USD5,702,000USD3,889,000USD2,584,000USD3,729,000USD
Total Liab46,330,000USD60,182,000USD135,017,000USD135,993,000USD143,324,000USD148,969,000USD146,347,000USD175,798,000USD
Total Stockholder Equity280,474,000USD486,926,000USD561,365,000USD622,042,000USD466,042,000USD184,006,000USD272,921,000USD322,998,000USD
Other Current Liab29,418,000USD29,271,000USD30,386,000USD22,962,000USD16,164,000USD16,183,000USD11,366,000USD11,757,000USD
Common Stock538,000USD538,000USD537,000USD521,000USD466,000USD399,000USD399,000USD399,000USD
Capital Stock538,000USD538,000USD537,000USD521,000USD466,000USD399,000USD399,000USD399,000USD
Retained Earnings-1,346,433,000USD-1,102,341,000USD-980,031,000USD-833,003,000USD-716,054,000USD-783,029,000USD-671,885,000USD-597,995,000USD
Cash307,531,000USD471,388,000USD618,830,000USD710,406,000USD579,094,000USD295,380,000USD375,723,000USD427,659,000USD
Cash And Short Term Investments307,531,000USD471,388,000USD618,830,000USD710,406,000USD579,094,000USD295,380,000USD375,723,000USD427,659,000USD
Total Current Assets315,193,000USD485,412,000USD639,282,000USD719,098,000USD584,809,000USD299,284,000USD378,375,000USD431,390,000USD
Total Current Liabilities40,843,000USD48,501,000USD56,891,000USD50,147,000USD33,452,000USD25,848,000USD17,714,000USD14,926,000USD
Current Deferred Revenue2,664,000USD8,850,000USD67,405,000USD11,442,000USD7,657,000USD4,927,000USD4,584,000USD110,242,000USD
Net Debt-293,671,000USD-460,545,000USD-606,995,000USD-703,933,000USD-566,768,000USD-277,542,000USD-352,784,000USD-376,113,000USD
Short Term Debt2,886,000USD2,610,000USD1,114,000USD6,473,000USD5,940,000USD5,512,000USD5,101,000USD1,645,000USD
Short Long Term Debt Total13,860,000USD10,843,000USD11,835,000USD6,473,000USD12,326,000USD17,838,000USD22,939,000USD51,546,000USD
Accounts Payable5,875,000USD7,770,000USD25,391,000USD9,270,000USD3,691,000USD4,117,000USD1,242,000USD1,470,000USD
Property Plant Equipment Net10,269,000USD13,789,000USD15,998,000USD8,008,000USD14,135,000USD20,362,000USD27,148,000USD52,835,000USD
Property Plant Equipment Gross17,321,000USD22,097,000USD23,413,000USD8,008,000USD14,135,000USD20,362,000USD27,148,000USD52,245,000USD
Common Stock Shares Outstanding53,829,000shares53,772,000shares53,216,000shares47,369,000shares48,464,000shares39,915,000shares39,882,000shares39,559,000shares
Non Current Assets Total11,611,000USD61,696,000USD57,100,000USD38,937,000USD24,557,000USD33,691,000USD40,893,000USD67,406,000USD
Non Current Liabilities Total5,487,000USD11,681,000USD78,126,000USD85,846,000USD109,872,000USD123,121,000USD128,633,000USD160,872,000USD
Non Currrent Assets Other482,000USD3,808,000USD7,209,000USD12,725,000USD3,351,000USD1,685,000USD3,789,000USD4,869,000USD
Net Working Capital274,350,000USD436,911,000USD582,391,000USD668,951,000USD551,357,000USD273,436,000USD360,661,000USD416,464,000USD
Unclassified Non Current Liabilities5,487,000USD11,681,000USD78,126,000USD—-103,486,000USD-110,795,000USD-110,795,000USD-110,971,000USD
Unclassified Equity1,625,831,000USD1,588,191,000USD1,540,322,000USD1,454,003,000USD1,181,164,000USD966,237,000USD952,015,000USD930,699,000USD
Net Receivables—0USD5,159,000USD62,000USD13,000USD15,000USD68,000USD2,000USD
Unclassified Non Current Assets—44,099,000USD33,893,000USD-12,725,000USD-3,351,000USD-19,496,000USD-3,789,000USD-4,869,000USD
Inventory——-5,159,000USD-62,000USD-13,000USD1,352,000USD-68,000USD1USD
Unclassified Current Liabilities——-67,405,000USD——-4,891,000USD-4,579,000USD-110,188,000USD
Other Liab———85,846,000USD103,486,000USD110,795,000USD110,795,000USD110,971,000USD
Other Assets———30,929,000USD10,422,000USD31,140,000USD13,745,000USD14,571,000USD
Accumulated Other Comprehensive Income———0USD0USD—-8,007,000USD-10,504,000USD
Non Current Liabilities Other———553,000USD6,939,000USD12,879,000USD18,391,000USD50,454,000USD
Net Tangible Assets———622,042,000USD466,042,000USD184,006,000USD272,921,000USD322,998,000USD
Deferred Long Term Liab————102,933,000USD110,242,000USD110,242,000USD110,418,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income32,721,000USD-21,589,000USD-36,541,000USD-125,767,000USD-60,195,000USD-57,956,000USD-59,001,000USD66,886,000USD
Depreciation184,000USD218,000USD229,000USD225,000USD223,000USD221,000USD-436,000USD231,000USD
Stock Based Compensation6,915,000USD7,074,000USD7,199,000USD12,418,000USD10,949,000USD10,520,000USD11,020,000USD12,041,000USD
Other Non Cash Items-4,464,000USD825,000USD715,000USD683,000USD688,000USD692,000USD-806,657USD662,000USD
Change In Working Capital-6,479,000USD-9,840,000USD-12,167,000USD21,190,000USD-3,356,000USD988,000USD5,579,000USD-61,053,000USD
Total Cash From Operating Activities28,877,000USD-23,312,000USD-40,565,000USD-46,340,000USD-53,363,000USD-47,772,000USD-45,186,000USD15,959,000USD
Capital Expenditures0USD-2,040USD-10,000USD-86,000USD-42,000USD-43,000USD-9,000USD-143,000USD
Free Cash Flow28,877,000USD-23,312,000USD-40,575,000USD-46,426,000USD-53,405,000USD-47,815,000USD-45,195,000USD15,816,000USD
Total Cash From Financing Activities-6,946,000USD2,051USD-17,000USD-74,000USD-48,000USD-59,000USD333,000USD444,000USD
Sale Purchase Of Stock-6,946,000USD-170,000USD-17,000USD-74,000USD-48,000USD-58,000USD-94,000USD-147,000USD
Change In Cash21,931,000USD-23,312,000USD-40,592,000USD-46,500,000USD-53,453,000USD-47,874,000USD-44,862,000USD16,260,000USD
Begin Period Cash Flow308,391,000USD331,703,000USD372,295,000USD418,795,000USD472,248,000USD520,122,000USD564,984,000USD548,724,000USD
End Period Cash Flow330,322,000USD308,391,000USD331,703,000USD372,295,000USD418,795,000USD472,248,000USD520,122,000USD564,984,000USD
Other Cashflows From Financing Activities-6,946,000USD145,405USD-18,795USD-78,609USD-48,000USD-1,000USD427,000USD591,000USD
Unclassified Financing Cash Flow6,946,000USD———————
Change To Account Receivables—0USD0USD0USD0USD0USD20,620USD-20,620USD
Total Cashflows From Investing Activities—2,036USD-10,000USD-86,000USD-42,000USD-43,000USD-9,000USD-143,000USD
Investments——-10,000USD-86,000USD-42,000USD-43,000USD-9,000USD-143,000USD
Unclassified Operating Cash Flow———44,911,000USD-1,672,000USD-2,237,000USD-1,541,343USD-2,808,000USD
Issuance Of Capital Stock—————0USD0USD0USD
Other Cashflows From Investing Activities——————984USD-984USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-244,092,000USD-122,310,000USD-147,028,000USD-116,949,000USD66,975,000USD-111,144,000USD-77,677,000USD-155,645,000USD
Depreciation895,000USD893,000USD928,000USD744,000USD1,115,000USD1,514,000USD6,820,000USD3,216,000USD
Stock Based Compensation37,640,000USD45,964,000USD40,914,000USD31,322,000USD24,658,000USD22,014,000USD23,585,000USD27,010,000USD
Other Non Cash Items2,911,000USD2,692,000USD7,499,000USD5,998,000USD5,688,000USD5,463,000USD37,303,000USD4,280,000USD
Change To Account Receivables0USD5,159,000USD-5,159,000USD79,000USD15,000USD53,000USD53,000USD238,000USD
Change In Working Capital-4,173,000USD-67,943,000USD-20,530,000USD-18,803,000USD-10,404,000USD3,479,000USD-4,449,000USD94,452,000USD
Total Cash From Operating Activities-163,580,000USD-150,050,000USD-133,906,000USD-108,821,000USD92,605,000USD-80,362,000USD-52,969,000USD-28,276,000USD
Capital Expenditures-138,000USD-298,000USD-2,810,000USD-464,000USD-575,000USD-196,000USD-555,000USD-1,768,000USD
Free Cash Flow-163,718,000USD-150,348,000USD-136,716,000USD-109,285,000USD92,030,000USD-80,558,000USD-53,524,000USD-30,044,000USD
Total Cashflows From Investing Activities-138,000USD-298,000USD-2,773,000USD-464,000USD-575,000USD-196,000USD-547,000USD-1,729,000USD
Total Cash From Financing Activities-139,000USD1,554,000USD45,103,000USD241,457,000USD190,332,000USD215,000USD228,000USD40,044,000USD
Sale Purchase Of Stock-139,000USD-353,000USD——93,593,000USD215,000USD228,000USD44,444,000USD
Issuance Of Capital Stock0USD0USD232,782,000USD223,616,000USD174,788,000USD78,367,000USD—39,758,000USD
Change In Cash-163,857,000USD-148,794,000USD-91,576,000USD132,172,000USD282,362,000USD-80,343,000USD-53,288,000USD10,039,000USD
Begin Period Cash Flow472,248,000USD621,042,000USD712,618,000USD580,446,000USD298,084,000USD378,427,000USD431,715,000USD421,676,000USD
End Period Cash Flow308,391,000USD472,248,000USD621,042,000USD712,618,000USD580,446,000USD298,084,000USD378,427,000USD431,715,000USD
Other Cashflows From Financing Activities-139,000USD1,907,000USD21,520,000USD17,841,000USD15,544,000USD215,000USD228,000USD4,686,000USD
Unclassified Operating Cash Flow43,239,000USD-9,346,000USD-15,689,000USD-11,133,000USD4,573,000USD-1,688,000USD-38,551,000USD-1,589,000USD
Investments—-298,000USD-1,412,000USD-464,000USD-575,000USD-196,000USD-547,000USD-1,729,000USD
Change To Inventory——-8,896,000USD—-10,275,000USD——9,600,000USD
Other Cashflows From Investing Activities——37,000USD———8,000USD39,000USD
Unclassified Investing Cash Flow——1,412,000USD————1,729,000USD
Unclassified Financing Cash Flow——-209,199,000USD—81,195,000USD——-4,686,000USD
Change To Liabilities———-1,990,000USD-144,000USD7,728,000USD-539,000USD85,075,000USD
Cash And Cash Equivalents Changes————282,362,000USD-80,343,000USD-53,288,000USD10,039,000USD
Net Borrowings———————-4,400,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2025Quarterly · 2025-03-31ProductCollaboration2,778,000USD0001559053-26-000017
Q1 2025Quarterly · 2025-03-31ProductLicense50,000USD0001559053-26-000017
Q3 2024Quarterly · 2024-09-30ProductCollaboration970,000USD0001559053-25-000044
Q3 2024Quarterly · 2024-09-30ProductLicense0USD0001559053-25-000044
Q2 2024Quarterly · 2024-06-30ProductCollaboration132,014,000USD0001559053-25-000031
Q2 2024Quarterly · 2024-06-30ProductLicense0USD0001559053-25-000031
Q1 2024Quarterly · 2024-03-31ProductCollaboration0USD0001559053-25-000023
Q1 2024Quarterly · 2024-03-31ProductLicense50,000USD0001559053-25-000023
Q4 2023Quarterly · 2023-12-31ProductCollaboration316,000USDLegacy provider
Q4 2023Quarterly · 2023-12-31ProductLicense0USDLegacy provider
FY 2023Yearly · 2023-12-31ProductCollaboration91,320,000USD0001559053-26-000008
FY 2023Yearly · 2023-12-31ProductLicense50,000USD0001559053-26-000008
Q3 2023Quarterly · 2023-09-30ProductCollaboration84,866,000USD0001559053-24-000032
Q3 2023Quarterly · 2023-09-30ProductLicense0USD0001559053-24-000032
Q2 2023Quarterly · 2023-06-30ProductCollaboration4,019,000USD0001559053-24-000025
Q2 2023Quarterly · 2023-06-30ProductLicense0USD0001559053-24-000025
Q1 2023Quarterly · 2023-03-31ProductCollaboration2,119,000USD0001559053-24-000014
Q1 2023Quarterly · 2023-03-31ProductLicense50,000USD0001559053-24-000014
FY 2020Yearly · 2020-12-31ProductCollaboration564,000USD0001559053-23-000005
FY 2020Yearly · 2020-12-31ProductLicense289,000USD0001559053-23-000005
FY 2019Yearly · 2019-12-31ProductCollaboration800,000USD0001559053-21-000008
FY 2019Yearly · 2019-12-31ProductLicense0USD0001559053-21-000008
FY 2019Yearly · 2019-12-31ProductOther14,000USD0001559053-21-000008

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.